TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10829585

Group type: EXPERIMENTAL
Intervention: Calcium-antagonists (non dihydropyridinic compounds)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard treatment or placebo)
Number of subjects: 0
Study: 8975835

Group type: EXPERIMENTAL
Intervention: Postoperative catheterization in inferior Q-wave infarction group (11 patients)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Postoperative catheterization in anterior Q-wave infarction group (6 patients)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Average peak postoperative creatine kinase MB levels
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Mortality at 3 years in patients with Q-wave infarctions
Number of subjects: 194
Study: 1414968

Group type: EXPERIMENTAL
Intervention: 30 mg beta-carotene/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 4003667

Group type: EXPERIMENTAL
Intervention: Metrifonate treatment (MIT, n = 202)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (MIP, n = 198)
Number of subjects: 250
Study: 30636728

Group type: COMPARATOR
Intervention: Stabilizing exercises (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Stabilizing exercises + pelvic floor muscles training (Group B)
Number of subjects: 40
Study: 28204953

Group type: EXPERIMENTAL
Intervention: Aln-NEF alone (70 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LT4 alone (600 μg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aln-NEF and LT4 concurrently
Number of subjects: 30
Study: 26050015

Group type: EXPERIMENTAL
Intervention: Galactomannan (GM)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: β-D-glucan (BG)
Number of subjects: 199
Study: 23188041

Group type: EXPERIMENTAL
Intervention: Marijuana-related visual cues
Number of subjects: 12
Study: 22097204

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 60
Study: 19497149

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg pre-pregnancy body weight)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (gelatin capsule)
Number of subjects: 27
Study: 16988210

Group type: EXPERIMENTAL
Intervention: Desmopressin administered as an oral lyophilisate dosage form; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin in children with nocturnal enuresis; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin in healthy adults; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 15531011

Group type: EXPERIMENTAL
Intervention: Insulin aspart injected immediately before the meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin aspart injected immediately after the meal
Number of subjects: 20
Study: 11309011

Group type: EXPERIMENTAL
Intervention: 1.0% ropivacaine with 50 IU/ml hyaluronidase
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.75% bupivacaine with 50 IU/ml hyaluronidase
Number of subjects: 40
Study: 9322572

Group type: EXPERIMENTAL
Intervention: Chromium picolinate supplementation (17.8 mumol Cr/d or 924 micrograms Cr/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-chromium placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistive training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chromium picolinate supplementation + Resistive training
Number of subjects: 18
Study: 7936311

Group type: EXPERIMENTAL
Intervention: deprenyl (10 mg/d)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: tocopherol (2,000 IU/d)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: both deprenyl and tocopherol
Number of subjects: 800

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 800
Study: 3070134

Group type: EXPERIMENTAL
Intervention: Levobunolol (0.5%)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Timolol (0.5%)
Number of subjects: 26
Study: 2405749

Group type: EXPERIMENTAL
Intervention: Biobrane
Number of subjects: 52
Study: 5472805

Group type: EXPERIMENTAL
Intervention: Pre-exercise inhalation of disodium cromoglycate
Number of subjects: 52
Study: 30873800

Group type: EXPERIMENTAL
Intervention: Knowledge of hepatitis B
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Knowledge of transmission methods
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Mean knowledge score
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Needle recapping behavior
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Vaccination status
Number of subjects: 358
Study: 28621003

Group type: EXPERIMENTAL
Intervention: BPT+AM
Number of subjects: 110

Group type: COMPARATOR
Intervention: BPT
Number of subjects: 110
Study: 26180226

Group type: EXPERIMENTAL
Intervention: Brief counseling focused on cessation goals and beliefs
Number of subjects: 522

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 522

Group type: COMPARATOR
Intervention: Low contact control group
Number of subjects: 522

Group type: COMPARATOR
Intervention: Motivated to quit (comparison group)
Number of subjects: 522
Study: 23432889

Group type: EXPERIMENTAL
Intervention: Nurse-led care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 21292872

Group type: EXPERIMENTAL
Intervention: Duffy (+) subjects exposed to P. vivax-infected mosquitoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Group A (Duffy +)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Groups B and C (Duffy +)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Treatment post-infection
Number of subjects: 22

Group type: COMPARATOR
Intervention: Duffy (‐) subjects
Number of subjects: 22
Study: 19906517

Group type: EXPERIMENTAL
Intervention: Phosphomonoester narrow resonance
Number of subjects: 54
Study: 16303216

Group type: EXPERIMENTAL
Intervention: 5 microg PRP-T
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: 1.25 microg PRP-T
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: 10 microg PRP-T
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: 4th booster dose of Hib
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: Primary immunization
Number of subjects: 1048

Group type: COMPARATOR
Intervention: DTP vaccination alone
Number of subjects: 1048
Study: 12531776

Group type: EXPERIMENTAL
Intervention: Once-weekly isoniazid/rifapentine
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control cases (not specified but implied to be twice-weekly isoniazid/rifampin)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Twice-weekly isoniazid/rifampin
Number of subjects: 133
Study: 12170675

Group type: EXPERIMENTAL
Intervention: SpeediCath (Coloplast)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lofric (Astra Tech)
Number of subjects: 27
Study: 9663957

Group type: EXPERIMENTAL
Intervention: Multistage shuttle run test
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maximal treadmill protocol
Number of subjects: 20
Study: 7824961

Group type: EXPERIMENTAL
Intervention: Fraxiparine 7500 IU
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fraxiparine 10000 IU
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enoxaparine 20 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enoxaparine 40 mg
Number of subjects: 6
Study: 3344486

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with plain bupivacaine for 48 hours and epidural morphine 4 mg every 8 hours for 96 hours plus systemic indomethacin 100 mg every 8 hours for 96 hours
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional postoperative pain treatment with intermittent nicomorphine (10 to 15 mg) and acetaminophen (1 gm) on request
Number of subjects: 24
Study: 29038876

Group type: EXPERIMENTAL
Intervention: IVC filters placed <1 cm below the renal vein
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: IVC filters placed 1-2 cm below the renal vein
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: IVC filters placed >2 cm below the renal vein
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: All filter placements
Number of subjects: 333
Study: 27287781

Group type: EXPERIMENTAL
Intervention: Atorvastatin at 10, 20, or 40 mg/day for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 26580869

Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) 595 nm applied on 3 occasions (after suture removal, 15 and 45 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simulated laser application
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (untreated half of the scar)
Number of subjects: 30
Study: 23701177

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) 0.7 mg daily for 40 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 20876393

Group type: EXPERIMENTAL
Intervention: Sucrose (0-1 M)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: NaCl (0-1 M)
Number of subjects: 15
Study: 18599555

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 44113

Group type: EXPERIMENTAL
Intervention: Combined HRT (progesterone + oestrogen)
Number of subjects: 44113
Study: 16390296

Group type: EXPERIMENTAL
Intervention: Attention training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Contact control (reading fluency training)
Number of subjects: 20
Study: 12749493

Group type: EXPERIMENTAL
Intervention: Permethrin-treated bed nets (ITNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control villages
Number of subjects: 0
Study: 11209585

Group type: EXPERIMENTAL
Intervention: 2% milk
Number of subjects: 51

Group type: COMPARATOR
Intervention: Whole milk
Number of subjects: 51
Study: 9388377

Group type: EXPERIMENTAL
Intervention: 1 alpha (OH)D3 (1 microgram/day) and calcium lactate
Number of subjects: 33

Group type: COMPARATOR
Intervention: calcium lactate alone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1 alpha (OH)D3 and calcium lactate
Number of subjects: 33
Study: 7945495

Group type: EXPERIMENTAL
Intervention: misoprostol (800 micrograms/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 3074463

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg orally b.i.d. for seven days
Number of subjects: 94

Group type: COMPARATOR
Intervention: Co-trimoxazole (160 mg of trimethoprim plus 800 mg of sulphamethoxazole) orally b.i.d. for seven days
Number of subjects: 94
Study: 31012741

Group type: EXPERIMENTAL
Intervention: Action-and-coping-planning intervention for forming a 'higher-order habit' of filling half of their dinner plates with fruits and vegetables
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 82
Study: 28693601

Group type: EXPERIMENTAL
Intervention: Model plate diet
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine dietary advice
Number of subjects: 120
Study: 26467429

Group type: EXPERIMENTAL
Intervention: Real acupuncture at KI3
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Real acupuncture at non‐acupoint
Number of subjects: 30
Study: 23333902

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg vs 80 mg
Number of subjects: 119
Study: 21540876

Group type: EXPERIMENTAL
Intervention: 20% blackcurrant juice drink (250 ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 20
Study: 19417960

Group type: EXPERIMENTAL
Intervention: 20 ml 0.5% levobupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 ml 0.5% bupivacaine
Number of subjects: 40
Study: 17558046

Group type: EXPERIMENTAL
Intervention: Niosomal methotrexate gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Marketed methotrexate gel
Number of subjects: 10
Study: 15128961

Group type: EXPERIMENTAL
Intervention: Quality improvement interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 11851027

Group type: EXPERIMENTAL
Intervention: Mitoxantrone 12 mg/m2 (n = 28)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Methylprednisolone 1 g (n = 21)
Number of subjects: 49
Study: 9657119

Group type: EXPERIMENTAL
Intervention: 3 x 3 MU rIFN-alpha
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 3 x 6 MU rIFN-alpha
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 3 x 6 MU rIFN-alpha plus 14 mg/kg ribavirin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: rIFN-alpha plus ribavirin
Number of subjects: 63

Group type: COMPARATOR
Intervention: rIFN-alpha
Number of subjects: 63
Study: 7859893

Group type: EXPERIMENTAL
Intervention: Co-active approach with patients
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Psychological and somatic aspects of the disease
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Predictive factors for co-active approach
Number of subjects: 70
Study: 2737781

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 10
Study: 788990

Group type: EXPERIMENTAL
Intervention: Levomethadone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Racemic methadone
Number of subjects: 66
Study: 31425384

Group type: EXPERIMENTAL
Intervention: Unsupervised isometric exercise (n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-and-see (n = 19)
Number of subjects: 40
Study: 31042696

Group type: EXPERIMENTAL
Intervention: MDMA (0.75 or 1.5 mg/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: MA (20 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 28550194

Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy (mean HbA1c of ∼7%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional diabetes therapy (mean HbA1c of 9%)
Number of subjects: 0
Study: 25545240

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 23392369

Group type: EXPERIMENTAL
Intervention: Midazolam/ketamine prior to lumbar puncture (Group A)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ketamine only prior to lumbar puncture (Group B)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-ketamine-sedated patients (Group C)
Number of subjects: 25
Study: 21069306

Group type: EXPERIMENTAL
Intervention: Tracing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Copying
Number of subjects: 16
Study: 20368377

Group type: EXPERIMENTAL
Intervention: Ayurvedic zinc tablet (jasad bhasma)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Zinc-rich snacks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 18040619

Group type: EXPERIMENTAL
Intervention: Insertion of an 8-mm Penrose drain retained below the liver bed for 42 hours (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No drain retained (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Insertion of an 8-mm Penrose drain (Group A)
Number of subjects: 120
Study: 15110726

Group type: EXPERIMENTAL
Intervention: Caucasian participants recognizing own-race faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asian participants recognizing own-race and other-race faces
Number of subjects: 0
Study: 11679507

Group type: EXPERIMENTAL
Intervention: Conscious sedation/local anaesthesia (group A)
Number of subjects: 67

Group type: COMPARATOR
Intervention: General anaesthesia (group B)
Number of subjects: 67
Study: 9692071

Group type: EXPERIMENTAL
Intervention: Fluoride (sodium fluoride 50 mg/day or monofluorophosphate 200 mg/day or 150 mg/day)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Calcium-vitamin D (1 g of calcium and 800 IU of vitamin D2 daily)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Fluoride
Number of subjects: 354

Group type: COMPARATOR
Intervention: Calcium-vitamin D
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Fluoride after cessation
Number of subjects: 354
Study: 8820898

Group type: EXPERIMENTAL
Intervention: Downhill running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10

Group type: COMPARATOR
Intervention: Level running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Uphill running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Treadmill speed at 4.0 mmol.l‐1 [La‐]b
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Correlation of RPE with HR at both [La‐]b
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Correlation of treadmill speed with RPE at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study: 2389831

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg/twice daily for 21 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6273020

Group type: EXPERIMENTAL
Intervention: Cortisone acetate (25 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Corticosteroid withdrawal
Number of subjects: 12
Study: 31852441

Group type: EXPERIMENTAL
Intervention: Semi-structured briefing (SG)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual routine (CG)
Number of subjects: 37
Study: 27810253

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided arthrocentesis
Number of subjects: 18

Group type: COMPARATOR
Intervention: Landmark-guided arthrocentesis
Number of subjects: 18
Study: 25970751

Group type: EXPERIMENTAL
Intervention: 250 g bilberries daily for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 g bilberries daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (inactive product - starch)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (debridement only)
Number of subjects: 0
Study: 25188752

Group type: EXPERIMENTAL
Intervention: ACCESS treatment model (integrated care including therapeutic assertive community treatment)
Number of subjects: 115
Study: 23159954

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study: 20145487

Group type: EXPERIMENTAL
Intervention: Functional Relaxation (FR)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Guided Imagery (GI)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Functional Relaxation and Guided Imagery (FR/GI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control Intervention (CI)
Number of subjects: 64
Study: 18576295

Group type: EXPERIMENTAL
Intervention: Chicken type II collagen (CCII) 0.1 mg/day
Number of subjects: 236

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 10 mg/week
Number of subjects: 236
Study: 15811207

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg ODT
Number of subjects: 608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 608
Study: 12219994

Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% eye drops
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nedocromil 2% eye drops
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10619342

Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge with different fish species
Number of subjects: 9

Group type: COMPARATOR
Intervention: Skin prick test
Number of subjects: 9

Group type: COMPARATOR
Intervention: RAST
Number of subjects: 9
Study: 8826270

Group type: EXPERIMENTAL
Intervention: Alternating-pressure supports
Number of subjects: 43

Group type: COMPARATOR
Intervention: Constant-low-pressure supports
Number of subjects: 43
Study: 1481761

Group type: EXPERIMENTAL
Intervention: Percutaneous pharyngostomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional nasal placement of nasogastric tubes
Number of subjects: 50
Study: 6377070

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study: 31181536

Group type: EXPERIMENTAL
Intervention: Pelvic sentinel lymph node (SLN) algorithm using indocyanine green (ICG)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Overall SLN algorithm (including macroscopically suspect nodes as SLNs)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Bilateral mapping rate
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: SLN procedure
Number of subjects: 257
Study: 29204652

Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 135
Study: 25693652

Group type: EXPERIMENTAL
Intervention: 1.2-mL bolus injection over 5 s
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 1 min
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 4 min
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 10 min
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All injections
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3.5-mL injections
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1.2-mL injections
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4-min injections
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1-min injections
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 10-min injections
Number of subjects: 48
Study: 23928715

Group type: EXPERIMENTAL
Intervention: Rocker sole shoes
Number of subjects: 115

Group type: COMPARATOR
Intervention: Flat sole shoes
Number of subjects: 115

Group type: COMPARATOR
Intervention: Flat sole shoes (for those reporting pain when standing and walking)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Rocker sole shoes (for those reporting pain when standing and walking)
Number of subjects: 115
Study: 21718484

Group type: EXPERIMENTAL
Intervention: Ginseng capsule (100 mg) twice daily for 24 weeks
Number of subjects: 168

Group type: COMPARATOR
Intervention: Matching placebo twice daily for 24 weeks
Number of subjects: 168
Study: 18829631

Group type: EXPERIMENTAL
Intervention: Topical prednisolone phosphate
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 17712235

Group type: EXPERIMENTAL
Intervention: Atomoxetine (n = 55)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo (n = 58)
Number of subjects: 176
Study: 15080599

Group type: EXPERIMENTAL
Intervention: HMB, arginine, and glutamine supplementation
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109